Panbela Therapeutics Inc
NASDAQ:PBLA
Income Statement
Earnings Waterfall
Panbela Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-25.6m
USD
|
Operating Income
|
-25.6m
USD
|
Other Expenses
|
384k
USD
|
Net Income
|
-25.3m
USD
|
Income Statement
Panbela Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1
N/A
|
1
+4%
|
1
-46%
|
0
-45%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(10)
|
(12)
|
(31)
|
(32)
|
(34)
|
(35)
|
(20)
|
(24)
|
(26)
|
|
Selling, General & Administrative |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
|
Research & Development |
(0)
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(7)
|
(26)
|
(27)
|
(28)
|
(29)
|
(14)
|
(18)
|
(21)
|
|
Operating Income |
(0)
N/A
|
(0)
-11%
|
(1)
-600%
|
(3)
-72%
|
(3)
-36%
|
(6)
-60%
|
(5)
+2%
|
(5)
+6%
|
(5)
-8%
|
(4)
+22%
|
(4)
+6%
|
(4)
-9%
|
(5)
-19%
|
(6)
-20%
|
(6)
-4%
|
(6)
+1%
|
(6)
+5%
|
(5)
+12%
|
(5)
+1%
|
(5)
+3%
|
(4)
+23%
|
(3)
+15%
|
(3)
+0%
|
(4)
-13%
|
(4)
-16%
|
(5)
-9%
|
(5)
0%
|
(5)
-14%
|
(6)
-7%
|
(7)
-19%
|
(8)
-17%
|
(8)
-3%
|
(10)
-22%
|
(12)
-17%
|
(31)
-162%
|
(32)
-5%
|
(34)
-6%
|
(35)
-3%
|
(20)
+44%
|
(24)
-22%
|
(26)
-8%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
1
|
1
|
1
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(0)
N/A
|
(0)
-14%
|
(2)
-546%
|
(3)
-70%
|
(4)
-38%
|
(6)
-59%
|
(6)
+2%
|
(5)
+6%
|
(6)
-6%
|
(4)
+23%
|
(4)
+4%
|
(4)
-7%
|
(5)
-21%
|
(10)
-88%
|
(11)
-5%
|
(11)
-3%
|
(11)
+1%
|
(7)
+36%
|
(8)
-15%
|
(8)
+6%
|
(6)
+19%
|
(6)
+2%
|
(6)
+4%
|
(6)
-10%
|
(7)
-4%
|
(7)
-3%
|
(5)
+27%
|
(5)
-4%
|
(5)
+2%
|
(6)
-9%
|
(7)
-35%
|
(8)
-11%
|
(11)
-28%
|
(12)
-13%
|
(32)
-165%
|
(34)
-6%
|
(35)
-4%
|
(36)
-4%
|
(20)
+44%
|
(24)
-17%
|
(25)
-7%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(0)
|
(0)
|
(1)
|
(3)
|
(4)
|
(6)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(4)
|
(5)
|
(10)
|
(10)
|
(10)
|
(10)
|
(7)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
(7)
|
(10)
|
(12)
|
(31)
|
(34)
|
(35)
|
(36)
|
(20)
|
(24)
|
(25)
|
|
Net Income (Common) |
(0)
N/A
|
(0)
-14%
|
(1)
-521%
|
(3)
-72%
|
(4)
-37%
|
(6)
-59%
|
(6)
+1%
|
(5)
+6%
|
(5)
+5%
|
(4)
+28%
|
(3)
+7%
|
(4)
-9%
|
(5)
-42%
|
(10)
-93%
|
(10)
-5%
|
(10)
-1%
|
(10)
+1%
|
(7)
+37%
|
(8)
-16%
|
(7)
+4%
|
(6)
+19%
|
(6)
+3%
|
(6)
+4%
|
(6)
-8%
|
(6)
-4%
|
(6)
-3%
|
(5)
+29%
|
(5)
-7%
|
(5)
+2%
|
(5)
-10%
|
(7)
-34%
|
(7)
-7%
|
(10)
-36%
|
(12)
-14%
|
(31)
-173%
|
(34)
-7%
|
(35)
-4%
|
(36)
-4%
|
(20)
+45%
|
(24)
-17%
|
(25)
-7%
|
|
EPS (Diluted) |
-1 754.44
N/A
|
-2 014.93
-15%
|
-3 937.99
-95%
|
-6 103.52
-55%
|
-8 293.38
-36%
|
-11 697.1
-41%
|
-11 536.38
+1%
|
-9 590.2
+17%
|
-4 201.6
+56%
|
-3 530.44
+16%
|
-1 672.76
+53%
|
-1 376.14
+18%
|
-1 974.66
-43%
|
-3 671.39
-86%
|
-3 573.65
+3%
|
-3 567.77
+0%
|
-3 491.22
+2%
|
-1 892.46
+46%
|
-2 286.21
-21%
|
-2 107.48
+8%
|
-1 520.07
+28%
|
-1 421.2
+7%
|
-1 306.23
+8%
|
-596
+54%
|
-1 305.32
-119%
|
-641
+51%
|
-456
+29%
|
-485.99
-7%
|
-476.99
+2%
|
-522.99
-10%
|
-701
-34%
|
-747.99
-7%
|
-1 014
-36%
|
-1 155
-14%
|
-3 147.99
-173%
|
-1 687
+46%
|
-1 746.5
-4%
|
-59.65
+97%
|
-5.53
+91%
|
-8.08
-46%
|
-232.43
-2 777%
|